New US Medicare pricing policies could reshape global pharmaceutical markets

A caller modeling survey published successful The Lancet suggests that U.S. Medicare's caller "Most-Favored-Nation" pricing policy, which ties what Medicare pays for medicines to prices charged successful different high-income countries, could propulsion pharmaceutical manufacturers to rise prices oregon hold launches. For astir 3 successful 4 medicines studied, the resulting Medicare savings would beryllium worthy astir 4 times that medicine's full yearly income successful the state utilized to acceptable its price, perchance giving manufacturers a beardown inducement to alteration however they terms and motorboat products extracurricular the U.S.